FCGBP Is a Promising Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Oral Squamous Cell Carcinoma
Author(s) -
Ting Shen,
Jianying Zhang,
Yali Wang,
Binjie Liu
Publication year - 2022
Publication title -
journal of immunology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.315
H-Index - 83
eISSN - 2314-8861
pISSN - 2314-7156
DOI - 10.1155/2022/8443392
Subject(s) - kegg , immune system , immunotherapy , proportional hazards model , downregulation and upregulation , cancer research , biomarker , cell , biology , basal cell , oncology , survival analysis , medicine , immunology , gene , gene expression , transcriptome , biochemistry , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom